However, previous studies have shown that SOCS2, as an anti-inflammatory substance, can inhibit inflammation and apoptosis during the progression of NASH by activating the activation of NF- κB, and its expression in macrophages was confirmed. This evidence concerns the gene SOCS2 and metabolic dysfunction-associated steatohepatitis.